BIV Receives APHIS Approval

Chuck Zimmerman

Boehringer IngelheimI wonder if they’re doing any radio for this announcement? Not only would the products be difficult to say but what they treat is even more difficult.

Boehringer Ingelheim receives approval
for simultaneous use of oral vaccines in swine

ST. JOSEPH, Mo. (July 19, 2005) – Boehringer Ingelheim Vetmedica, Inc., received approval for simultaneous use of Enterisol® Ileitis FF, Enterisol® SC-54 FF and Ingelvac® ERY-ALC from the Animal and Plant Health Inspection Service (APHIS) division of the Department of Agriculture.

The new claim allows swine producers to administer the three oral vaccines simultaneously while maintaining the efficacy of each vaccine and saving management time and labor expenses. The use of simultaneous vaccination also allows veterinarians and producers the option to utilize a single medication-free window for oral vaccine administration.

For more information contact R. Kelly Schwalbe at 816-474-3166.

Agribusiness